comparemela.com

Latest Breaking News On - Fondazioneg pascale - Page 1 : comparemela.com

Intensified ABVD Bests PET-Adapted ABVD as First-Line Therapy for Hodgkin Lymphoma

Intensified ABVD can improve outcomes vs PET-adapted ABVD in previously untreated Hodgkin lymphoma, a phase 3 study suggests.

Healthcare Brief (04/22/21) - D Magazine

Healthcare Brief (04/22/21) Texas Health is No. 7 on Fortune s best places to work list, Medical City Plano earns Level IV maternal designation, and more. By Will Maddox Published in Healthcare Business April 21, 2021 11:00 pm Texas Health Resources is now No. 7 on Fortune’s 100 Best Companies to Work For list after being ranked No. 15 last year. The health system is the top employer in the state and the top ranked health system in the nation. Texas Health has made the list seven years in a row, and is the ranking is decided based on employee feedback surveys. Medical City Plano earned a Level IV Maternal Designation, the highest level of care designated by the Texas Department of State Health Services. This designation means the hospital provides comprehensive care for pregnant and postpartum patients with a wide range of risk and includes medical subspecialists, surgical specialists and behavioral health support.

Pascale Foundation, Member of Italy s Institute of Hospitalization and Treatment, Joins Caris Life Sciences Precision Oncology Alliance

Pascale Foundation, Member of Italy s Institute of Hospitalization and Treatment, Joins Caris Life Sciences Precision Oncology Alliance News provided by Share this article Share this article IRVING, Texas, April 6, 2021 /PRNewswire/  Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today that the Istituto Nazionale Tumori IRCCS Fondazione G. Pascale (Pascale Foundation) has joined Caris Precision Oncology Alliance™ (POA). The POA is a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards of care for molecular testing in oncology through research focused on predictive and prognostic markers that improve the clinical outcomes of patients with cancer.

Pascale Foundation, Member of Italys Institute of Hospitalization and Treatment, Joins Caris Life Sciences Precision Oncology Alliance

IRVING, Texas, April 6, 2021 – Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today that the Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale” (Pascale Foundation) has joined Caris’ Precision Oncology Alliance™ (POA). The POA is a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards of care for molecular testing in oncology through research focused on predictive and prognostic markers that improve the clinical outcomes of patients with cancer. Pascale Foundation is the largest clinical care and research cancer center in Southern Italy. The institute pursues clinical research and applied research in the biomedical field, along with the organization and management of health services. Pascale Foundation focuses on patient-centered care through research and innovation in dail

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.